Dr. Neal K. Osborn, MD

Dr. Osborn practices at Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System.

Dr. Osborn's NPI, 1124005442, was assigned on December 28, 2005. Dr. Osborn graduated from Creighton University School of Medicine in 1999. Dr. Osborn holds Georgia license 058553.

Dr. Osborn's primary practice is Wellstar North Fulton Medical Center, at 3000 Hospital Boulevard, Roswell, GA 30076 in Fulton County. The practice phone is (770) 751-2500.

Dr. Osborn's primary practice is Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System. Dr. Osborn is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Atlanta Gastroenterology Associates. Dmand AI also links Dr. Osborn to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Osborn practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Osborn's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Osborn's licenses on file in 2 states: Georgia and Minnesota.

CMS data shows 760 Medicare services from Dr. Osborn across 18 procedure codes in 2024, for 395 Medicare patients. Medicare paid $83,857 for them.

CMS counts 395 Medicare patients who saw Dr. Osborn in 2024. The largest group is 65 to 74, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Osborn's median patient age at 62, with 55% women.

In 2024, Dr. Osborn wrote 2,369 Medicare Part D claims for 629 patients. 74% of them were for generic drugs. CMS names the drug for 2,144 of them, across 33 drugs with 11 or more claims each, at $2,169,699 in total drug cost. In 2023, CMS named 1,771 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Osborn for performance year 2024, reported individually. Dr. Osborn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 109 procedures of colonoscopy by Dr. Osborn, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Osborn, published from 2011 to 2013. 2013 was the busiest year, with 2. Dr. Osborn's most frequent co-authors are David F. Ransohoff, MD, Lisa A. Boardman, MD and Suresh T. Chari, MD.

CMS Open Payments shows 1,929 general payments to Dr. Osborn from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Janssen Pharmaceuticals, Inc paid the most, $172,137.

Dr. Osborn graduated from Creighton University School of Medicine in 1999.